Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Pacific Biosciences (PACB) has a market cap of $0.38 billion USD. According to our data, Pacific Biosciences is ranked No.6261 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $0.38 B |
-29.77%
|
| Dec 31, 2024 | $0.54 B |
-81.35%
|
| Dec 29, 2023 | $2.89 B |
19.93%
|
| Dec 30, 2022 | $2.41 B |
-60.02%
|
| Dec 31, 2021 | $6.02 B |
-21.13%
|
| Dec 31, 2020 | $7.63 B |
404.67%
|
| Dec 31, 2019 | $1.51 B |
-30.54%
|
| Dec 31, 2018 | $2.18 B |
180.30%
|
| Dec 29, 2017 | $0.78 B |
-30.53%
|
| Dec 30, 2016 | $1.12 B |
-71.06%
|
| Dec 31, 2015 | $3.86 B |
67.47%
|
| Dec 31, 2014 | $2.31 B |
49.90%
|
| Dec 31, 2013 | $1.54 B |
207.65%
|
| Dec 31, 2012 | $0.50 B |
-39.29%
|
| Dec 30, 2011 | $0.82 B |
-82.40%
|
| Dec 31, 2010 | $4.68 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Illumina
ILMN
|
$11.80 B |
-0.000 M
|
USA
|
 Thermo Fisher Scientific
TMO
|
$166.47 B |
0.002 M
|
USA
|
 Qiagen
QGEN
|
$8.98 B |
0.000 M
|
Netherlands
|
 Agilent Technologies
A
|
$29.40 B |
-0.001 M
|
USA
|
 Bio-Rad Laboratories
BIO
|
$6.82 B |
1.204 B
|
USA
|
 Becton Dickinson
BDX
|
$58.01 B |
-0.001 M
|
USA
|
 10x Genomics
TXG
|
$1.00 B |
0.115 B
|
USA
|
 Danaher
DHR
|
$135.88 B |
0.003 M
|
USA
|
 Bruker
BRKR
|
$5.82 B |
0.000 M
|
USA
|
 Myriad Genetics
MYGN
|
$0.74 B |
-0.000 M
|
USA
|
| Market Cap | = | PACB Stock Price | * | PACB Shares Outstanding |
| = | $1.27 | * | 0.30 B | |
| = | $0.38 B |